PRESS RELEASE published on 01/28/2025 at 14:14, 1 year 7 months ago Inside Information / Other news releases Arkema discloses trading in own shares from 20 to 23 January 2025, totaling 16,000 shares bought back. Details available on Arkema's investor relations website Share Buyback Investor Relations Trading 2025 ARKEMA
PRESS RELEASE published on 01/28/2025 at 14:14, 1 year 7 months ago Informations privilégiées / Autres communiqués Arkema annonce avoir effectué des achats d'actions propres conformément à la réglementation. Les détails des transactions sont disponibles sur leur site internet Actions Propres Rachat D'actions Transactions Site Internet ARKEMA
BRIEF published on 01/27/2025 at 09:47, 1 year 7 months ago BlackRock dépasse le seuil de 5% du capital d'ARKEMA Capital Franchissement De Seuil Actions BlackRock ARKEMA
BRIEF published on 01/27/2025 at 09:47, 1 year 7 months ago BlackRock exceeds the 5% threshold of ARKEMA's capital Capital Actions BlackRock Threshold Crossing ARKEMA
PRESS RELEASE published on 01/27/2025 at 09:42, 1 year 7 months ago Franchissement de seuil Déclaration de franchissement de seuil par BlackRock Inc. pour le compte de clients et de fonds détenant 5,36% du capital d'ARKEMA Franchissement De Seuil BlackRock Inc. Acquisition Actions ARKEMA Gestionnaire D'investissement
BRIEF published on 01/21/2025 at 15:47, 1 year 7 months ago Arkema Carries Out Share Buybacks from January 13 to 17, 2025 Transactions Share Buyback Financial Market Regulation EU 596/2014 ARKEMA
BRIEF published on 01/21/2025 at 15:47, 1 year 7 months ago Arkema procède à des rachats d'actions du 13 au 17 janvier 2025 Marché Financier Rachat D'actions Transactions ARKEMA Règlement UE 596/2014
PRESS RELEASE published on 01/21/2025 at 15:42, 1 year 7 months ago Inside Information / Other news releases Arkema discloses share buyback transactions for own shares from 13 to 17 January 2025 in compliance with regulations. Total daily volume: 17,500 shares. Weighted average price: 72,9529. More details on Arkema's website Trading Disclosure Share Buyback Investor Relations Regulation Compliance ARKEMA
PRESS RELEASE published on 01/21/2025 at 15:42, 1 year 7 months ago Informations privilégiées / Autres communiqués Arkema déclare avoir acheté 17 500 actions propres entre le 13 janvier et le 17 janvier 2025, conformément à la réglementation en vigueur Actions Propres Rachat D'actions Transactions Réglementation ARKEMA
BRIEF published on 01/14/2025 at 16:02, 1 year 7 months ago Arkema déclare ses transactions sur actions propres de janvier 2025 XPAR Achat D'actions Prix Moyen ARKEMA Janvier 2025
Published on 09/11/2026 at 04:00, 6 hours 30 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 12 hours 5 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 19 hours 10 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 30 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 15 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 10 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 25 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour 30 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours 30 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 3 hours 30 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 hours 30 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
